Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/91245
| Title: | Peptides for specific inhibition of Jag 1-Notch 1 pathway | Authors: | Zhu, X Chen, Y Chan, THW Chow, MC |
Issue Date: | 14-Sep-2021 | Source: | US Patent 11,117,932 B2. Washington, DC: US Patent and Trademark Office, 2021. | Abstract: | Aberrant cross talk between Notch ligand (e.g. Jag1) and Notch receptor (e.g. Notch1) has been implicated in tumorigenesis in the colon. Inhibition of Notch pathway is therefore an attractive approach for treating diseases with upregulated Jag1 e.g. colorectal cancer (CRC). Pan-notch inhibitors like gamma secretase inhibitors (GSIs) have been developed to inhibit Notch and its downstream events. However, severe gastrointestinal toxicity profiles impede the clinical development of GSIs. The present invention develops novel oligopeptides that specifically inhibit Jag1-Notch1 pathway without interfering DLL1-Notch1 or DLL4-Notch1, which demonstrates a clear advantage over pan-notch inhibitors. | Rights: | Assignee: The Hong Kong Polytechnic University Assignee: The Royal Institution for the Advancement of Learning/McGill University |
| Appears in Collections: | Patent |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| us11117932b2.pdf | 1.84 MB | Adobe PDF | View/Open |
Page views
79
Last Week
0
0
Last month
Citations as of Sep 17, 2023
Downloads
4
Citations as of Sep 17, 2023
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.